Auditing
Key Benefits
You know where you stand before the regulatory agency tells you
You have the opportunity to proactively address non-conformances
You reduce the possibility of warning letters and hold points
Capabilities
Note: further details regarding audit syllabi are provided for underlined topics
GMPs
GLPs
GCPs
ISO 9000-9004
QS-9000
ISO 14000
Regulatory
Pre-Submission
Supplier/Vendor
FDA Applications Integrity (Fraud Policy)
Due Diligence
Return to Home Page
- QSRs
Design Control Inspectional Strategy
- General
Design and Development Planning
Design Input
Design Output
Design Review
Design Verification
Design Validation
Design transfer
Design Changes
Design History File- Return to Capabilities List Return to Home Page
- GLPs
LABORATORY ORGANIZATION & MANAGEMENT
QUALITY ASSURANCE SYSTEM
QUALITY CONTROL SYSTEMS
LABORATORY PERSONNEL
ENVIRONMENT AND FACILITIES
EQUIPMENT
STANDARD OPERATING PROCEDURES (SOPs)/PROTOCOLS/TEST METHODS
HANDLING OF REAGENTS/SOLUTIONS AND TEST/CONTROL ARTICLES
STUDY CONDUCT
REPORTS
RECORD RETENTION
SUBCONTRACTED/OUTSIDE SUPPORT, SERVICES, AND/OR SUPPLIES
COMPLAINTS
- GCPs
Investigator Site AuditEvaluation and Initiation of Study
CRO Audit
Responsibilities of Sponsor/Monitor
Responsibilities of Investigator
Informed Consent
Regulatory Documents
Mid-Study (Monitoring)
Close-Out of StudyLaboratory Audit
- Selection of CRO
Phase 1 Units
Close-Out of StudyIRB Audit
Sponsor Audit
Return to Capabilities List Return to Home Page
- Clinical Investigation
Biopharmaceutics
Computer Systems Validation
- ISO 9000-9004
Management Responsibility
Quality System
Contract Review
Design Control
Document and Data Control
Purchasing
Control of Customer-supplied Product
Product Identification and Traceability
Process Control
Inspection and Testing
Control of Inspection, Measuring and Test Equipment
Inspection and Test Status
Control of Nonconforming Product
Corrective and Preventive Action
Handling, Storage, Packaging, Preservation and Delivery
Control of Quality Records
Internal Quality Audits
Training
Servicing
Statistical Techniques
Return to Capabilities List Return to Home Page
QS-9000ISO 9000 Based Requirements
Management Responsibility
Quality System
Contract Review
Design Control
Document and Data Control
Purchasing
Control of Customer-supplied Product
Product Identification and Traceability
Process Control
Inspection and Testing
Control of Inspection, Measuring and Test Equipment
Inspection and Test Status
Control of Nonconforming Product
Corrective and Preventive Action
Handling, Storage, Packaging, Preservation and Delivery
Control of Quality Records
Internal Quality Audits
Training
Servicing
Statistical Techniques
- ISO 14000
Standard Title / Description 14000 Guide to Environmental Management Principles, Systems and Supporting Techniques 14001 Environmental Management Systems - Specification with Guidance for Use 14010 Guidelines for Environmental Auditing - General Principles of Environmental Auditing 14011 Guidelines for Environmental Auditing - Audit Procedures-Part 1: Auditing of Environmental Management Systems 14012 Guidelines for Environmental Auditing - Qualification Criteria for Environmental Auditors 14013/15 Guidelines for Environmental Auditing - Audit Programs, Reviews & Assessments 14020/23 Environmental Labeling 14024 Environmental Labeling - Practitioner Programs - Guiding Principles, Practices and Certification Procedures of Multiple Criteria Programs 14031/32 Guidelines on Environmental Performance Evaluation 14040/43 Life Cycle Assessment General Principles and Practices 14050 Glossary 14060 Guide for the Inclusion of Environmental Aspects in Product Standards
Return to Capabilities List Return to Home Page
Regulatory
Information Control
Device Listing
IDE
510(K)
PMA's
Custom Devices
Pre-Submission
(Click on the above title)
- Return to Capabilities List Return to Home Page
Supplier/VendorThis type of assessment is unique to each occasion. The criteria is agreed upon between Sequitur and our client prior to the assessment.
FDA Applications Integrity (Fraud Policy)
Internal Review
- Problems analysis as stated by FDA
- Audit Plan
- Purpose
- Person Developing Plan
- Content
- Scope
- Controls to Assure Impartiality
- Qualifications of Consultant
- Projected time frames of Audit
- Specifications of Final Audit Report
Return to Capabilities List Return to Home Page
- Audit per audit plan
- Nonclinical and Clinical Studies
Manufacturing Processes
- Protocol
- Study Report
- Specimen Examination
- Personnel
- Raw materials, components, ingredients
- Test Records
- Production and Process Records
- Equipment
Audit Report
- In Vivo Bioequivilence and Bioavailability Studies
Corrective Action Operating Plan
- Content
Implementation
- Audit findings analysis
- Disposition of auditor's recommendations
- Description of actions to correct fraud/other wrongful acts ID'd by FDA/discovered by internal review
- Implementation timetable
- ID of Persons responsible for timely corrective actions
- Ethics Program describing standards/procedures for employees about program and for enforcing program
- Procedures for monitoring effectiveness of operating plan and to assure product will be built per GMPs and other applicable requirements
- Plan to train Supv, tech and scientific employees in FD&C Act, and 18 USC 1001
Verification
Due Diligence
This type of assessment is unique to each occasion. The criteria is agreed upon between Sequitur and our client prior to the assessment
Return to Capabilities List Return to Home Page